Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study

Abstract Background Sinus tachycardia coupled with high-dose catecholamine is common after cardiopulmonary bypass (CPB). The present study assessed the hemodynamic efficacy and safety of combination therapy using low-dose β1-selective adrenergic blocker (landiolol) and inotropes. Methods This was a...

Full description

Bibliographic Details
Main Authors: Michihiro Sakai, Satoshi Jujo, Junjiro Kobayashi, Yoshihiko Ohnishi, Masataka Kamei
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13019-019-0966-z
_version_ 1828451106056830976
author Michihiro Sakai
Satoshi Jujo
Junjiro Kobayashi
Yoshihiko Ohnishi
Masataka Kamei
author_facet Michihiro Sakai
Satoshi Jujo
Junjiro Kobayashi
Yoshihiko Ohnishi
Masataka Kamei
author_sort Michihiro Sakai
collection DOAJ
description Abstract Background Sinus tachycardia coupled with high-dose catecholamine is common after cardiopulmonary bypass (CPB). The present study assessed the hemodynamic efficacy and safety of combination therapy using low-dose β1-selective adrenergic blocker (landiolol) and inotropes. Methods This was a retrospective, single center, self-comparison study at post-anesthesia care unit within a tertiary care center. The study included adults who underwent cardiac surgery with CPB and received landiolol between April 2007 and November 2011. We assessed hemodynamic data prior to and 1 h after initiation of landiolol therapy. Results We evaluated 11 patients who were administered 2.6 ± 1.3 μg/kg/min (mean ± SD) landiolol with sinus tachycardia and received catecholamine therapy after on-pump cardiovascular surgery. Landiolol administration led to a significant reduction in heart rate (HR; 112.4 ± 5.8 vs 126.0 ± 7.6 beats/min, p < 0.001), and a significant increase in stroke volume index (SVI) assessed by pulmonary artery catheterization (22.4 ± 5.4 vs. 18.9 ± 4.2 mL/m2, p = 0.04). Only one patient showed no HR reduction, whereas seven patients showed decreased HR and increased SVI (64, 95% confidence interval: 30–98%). Moreover, all five patients who received high-dose catecholamine support showed improved hemodynamics. In terms of safety, no patients required cessation of landiolol therapy. Conclusions Low-dose landiolol therapy may safely decrease HR and improve hemodynamics among patients with sinus tachycardia receiving catecholamine treatment after cardiovascular surgery. Trial registration This study is retrospective. Registration number: 11. Duration of registration: April 2007~November 2011.
first_indexed 2024-12-10T23:32:07Z
format Article
id doaj.art-c92ca83f48684a9e8c0d7669883915b0
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-12-10T23:32:07Z
publishDate 2019-07-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-c92ca83f48684a9e8c0d7669883915b02022-12-22T01:29:21ZengBMCJournal of Cardiothoracic Surgery1749-80902019-07-011411610.1186/s13019-019-0966-zUse of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective studyMichihiro Sakai0Satoshi Jujo1Junjiro Kobayashi2Yoshihiko Ohnishi3Masataka Kamei4Department of Clinical Anesthesiology, Mie University HospitalDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Clinical Anesthesiology, Mie University HospitalAbstract Background Sinus tachycardia coupled with high-dose catecholamine is common after cardiopulmonary bypass (CPB). The present study assessed the hemodynamic efficacy and safety of combination therapy using low-dose β1-selective adrenergic blocker (landiolol) and inotropes. Methods This was a retrospective, single center, self-comparison study at post-anesthesia care unit within a tertiary care center. The study included adults who underwent cardiac surgery with CPB and received landiolol between April 2007 and November 2011. We assessed hemodynamic data prior to and 1 h after initiation of landiolol therapy. Results We evaluated 11 patients who were administered 2.6 ± 1.3 μg/kg/min (mean ± SD) landiolol with sinus tachycardia and received catecholamine therapy after on-pump cardiovascular surgery. Landiolol administration led to a significant reduction in heart rate (HR; 112.4 ± 5.8 vs 126.0 ± 7.6 beats/min, p < 0.001), and a significant increase in stroke volume index (SVI) assessed by pulmonary artery catheterization (22.4 ± 5.4 vs. 18.9 ± 4.2 mL/m2, p = 0.04). Only one patient showed no HR reduction, whereas seven patients showed decreased HR and increased SVI (64, 95% confidence interval: 30–98%). Moreover, all five patients who received high-dose catecholamine support showed improved hemodynamics. In terms of safety, no patients required cessation of landiolol therapy. Conclusions Low-dose landiolol therapy may safely decrease HR and improve hemodynamics among patients with sinus tachycardia receiving catecholamine treatment after cardiovascular surgery. Trial registration This study is retrospective. Registration number: 11. Duration of registration: April 2007~November 2011.http://link.springer.com/article/10.1186/s13019-019-0966-zTachycardiaCatecholamineCardiovascular surgery
spellingShingle Michihiro Sakai
Satoshi Jujo
Junjiro Kobayashi
Yoshihiko Ohnishi
Masataka Kamei
Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
Journal of Cardiothoracic Surgery
Tachycardia
Catecholamine
Cardiovascular surgery
title Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
title_full Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
title_fullStr Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
title_full_unstemmed Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
title_short Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
title_sort use of low dose β1 blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery a retrospective study
topic Tachycardia
Catecholamine
Cardiovascular surgery
url http://link.springer.com/article/10.1186/s13019-019-0966-z
work_keys_str_mv AT michihirosakai useoflowdoseb1blockerforsinustachycardiainpatientswithcatecholaminesupportfollowingcardiovascularsurgeryaretrospectivestudy
AT satoshijujo useoflowdoseb1blockerforsinustachycardiainpatientswithcatecholaminesupportfollowingcardiovascularsurgeryaretrospectivestudy
AT junjirokobayashi useoflowdoseb1blockerforsinustachycardiainpatientswithcatecholaminesupportfollowingcardiovascularsurgeryaretrospectivestudy
AT yoshihikoohnishi useoflowdoseb1blockerforsinustachycardiainpatientswithcatecholaminesupportfollowingcardiovascularsurgeryaretrospectivestudy
AT masatakakamei useoflowdoseb1blockerforsinustachycardiainpatientswithcatecholaminesupportfollowingcardiovascularsurgeryaretrospectivestudy